MedAvail Holdings, Inc. (MDVL)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
MedAvail Holdings, Inc. (MDVL) with AI Score 49/100 (Weak). MedAvail Holdings, Inc. operates as a technology-enabled retail pharmacy, providing self-service pharmacy solutions in the United States and Canada. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 17, 2026MedAvail Holdings, Inc. (MDVL) Healthcare & Pipeline Overview
MedAvail Holdings, Inc. focuses on revolutionizing pharmacy services through its MedCenter kiosks and SpotRx platform, offering convenient prescription dispensing in diverse settings. The company operates in the evolving healthcare sector, emphasizing technology-driven solutions to enhance patient access and streamline pharmacy operations across the United States and Canada.
Investment Thesis
MedAvail Holdings, Inc. presents a unique investment opportunity within the healthcare technology sector. The company's innovative MedCenter kiosks and SpotRx platform address the growing demand for convenient and accessible pharmacy services. Key value drivers include the expansion of the MedCenter kiosk network, increased adoption of the SpotRx platform, and strategic partnerships with healthcare providers and employers. The company's negative P/E ratio of -0.05 reflects its current lack of profitability, while its negative profit margin of -110.5% indicates significant operational challenges. However, the company's growth potential lies in its ability to capture a larger share of the retail pharmacy market through its technology-driven solutions. A beta of -0.14 suggests low volatility relative to the market. The company's ability to improve its gross margin of 6.0% and achieve profitability will be critical to its long-term success.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $0.00B indicates the company's small size and potential for growth.
- P/E ratio of -0.05 reflects current losses and the need for improved profitability.
- Profit margin of -110.5% highlights significant operational challenges and the need for cost optimization.
- Gross margin of 6.0% indicates limited profitability on sales and the need for improved pricing strategies.
- Beta of -0.14 suggests low volatility compared to the overall market.
Competitors & Peers
Strengths
- Innovative MedCenter kiosk technology.
- Established SpotRx retail pharmacy platform.
- Strategic partnerships with healthcare providers.
- Experienced management team.
Weaknesses
- Negative profitability and high operating expenses.
- Limited market share in a competitive industry.
- Dependence on strategic partnerships for growth.
- Regulatory risks associated with pharmacy operations.
Catalysts
- Upcoming: Expansion of MedCenter kiosk network into new geographic markets.
- Ongoing: Increased adoption of SpotRx platform by patients and healthcare providers.
- Ongoing: Strategic partnerships with healthcare providers and employers.
Risks
- Potential: Competition from traditional retail pharmacies and mail-order pharmacies.
- Potential: Evolving regulatory landscape for pharmacy operations.
- Ongoing: Negative profitability and high operating expenses.
- Potential: Technological obsolescence.
Growth Opportunities
- Expansion of MedCenter Kiosk Network: MedAvail has the opportunity to expand its MedCenter kiosk network across the United States and Canada. By partnering with healthcare providers, employers, and retailers, the company can increase its footprint and reach a wider patient base. The market for on-site pharmacy services is growing, driven by the demand for convenient and accessible prescription dispensing. The company can target locations with high patient traffic, such as medical clinics, retail stores, and employer sites, to maximize the utilization of its MedCenter kiosks. This expansion could significantly increase revenue and market share within the next 3-5 years.
- Increased Adoption of SpotRx Platform: MedAvail can drive growth through increased adoption of its SpotRx retail pharmacy platform. By enhancing the platform's features and functionality, the company can attract more patients and healthcare providers. The market for online pharmacy services is expanding rapidly, driven by the increasing use of mobile devices and the demand for convenient prescription refills. MedAvail can leverage its SpotRx platform to capture a larger share of this market and generate recurring revenue. This growth opportunity is expected to materialize within the next 2-3 years.
- Strategic Partnerships with Healthcare Providers: MedAvail can forge strategic partnerships with healthcare providers to integrate its MedCenter kiosks and SpotRx platform into their existing workflows. By collaborating with physicians, hospitals, and other healthcare organizations, the company can streamline the prescription fulfillment process and improve patient outcomes. The market for integrated healthcare solutions is growing, driven by the need for coordinated and efficient care delivery. MedAvail can leverage its technology-driven solutions to become a valuable partner for healthcare providers and expand its market reach. These partnerships could yield significant benefits within the next 1-2 years.
- Development of New Pharmacy Technology Solutions: MedAvail can invest in the development of new pharmacy technology solutions to address emerging market needs. By innovating and expanding its product portfolio, the company can differentiate itself from competitors and capture new revenue streams. The market for pharmacy technology is constantly evolving, driven by advancements in artificial intelligence, machine learning, and other technologies. MedAvail can leverage these technologies to develop solutions that improve medication adherence, reduce prescription errors, and enhance patient engagement. These new solutions could be launched within the next 3-5 years.
- Expansion into New Geographic Markets: MedAvail can explore opportunities to expand its operations into new geographic markets beyond the United States and Canada. By entering new countries and regions, the company can diversify its revenue streams and reduce its reliance on existing markets. The global market for pharmacy services is large and growing, driven by increasing healthcare spending and the aging of the population. MedAvail can leverage its technology-driven solutions to enter new markets and establish a global presence. This expansion could occur within the next 5-7 years.
Opportunities
- Expansion of MedCenter kiosk network.
- Increased adoption of SpotRx platform.
- Development of new pharmacy technology solutions.
- Entry into new geographic markets.
Threats
- Competition from traditional retail pharmacies and mail-order pharmacies.
- Evolving regulatory landscape for pharmacy operations.
- Technological obsolescence.
- Economic downturn affecting healthcare spending.
Competitive Advantages
- Proprietary MedCenter kiosk technology.
- Established network of MedCenter kiosks in strategic locations.
- Strong relationships with healthcare providers and employers.
- Scalable SpotRx retail pharmacy platform.
About MDVL
MedAvail Holdings, Inc. is a technology-enabled retail pharmacy company that develops and commercializes self-service pharmacy solutions. Founded with the vision of improving access to prescription medications, MedAvail operates in two segments: Retail Pharmacy Services and Pharmacy Technology. The company's core offering is the MedCenter, a self-service kiosk that enables on-site pharmacy services in various locations, including medical clinics, retail stores, and employer sites. These kiosks provide an audio-visual connection to a live pharmacist, ensuring real-time supervision and patient counseling during prescription dispensing. MedAvail also owns and operates SpotRx, a retail pharmacy platform designed to enhance convenience and accessibility for patients. As of December 31, 2021, the company had 81 MedCenter kiosks deployed. The company's solutions aim to streamline the prescription fulfillment process, reduce wait times, and improve medication adherence. MedAvail's geographic focus includes the United States and Canada, where it seeks to partner with healthcare providers, employers, and retailers to expand its network of MedCenter kiosks and SpotRx pharmacies. The company is headquartered in Mississauga, Canada, and employs 279 individuals dedicated to its mission of transforming the pharmacy experience.
What They Do
- Develops and commercializes self-service pharmacy kiosks.
- Operates MedCenter kiosks for on-site prescription dispensing.
- Provides audio-visual connection to live pharmacists for patient consultation.
- Owns and operates the SpotRx retail pharmacy platform.
- Offers mobile application for convenient prescription management.
- Provides drive-thru pharmacy solutions.
Business Model
- Generates revenue through the sale of prescription medications at MedCenter kiosks and SpotRx pharmacies.
- Earns fees from healthcare providers and employers for providing on-site pharmacy services.
- Derives revenue from technology licensing and service agreements.
Industry Context
MedAvail Holdings, Inc. operates within the medical pharmaceuticals industry, which is experiencing a shift towards technology-enabled solutions. The market is driven by increasing demand for convenient and accessible healthcare services, particularly in prescription fulfillment. The competitive landscape includes traditional retail pharmacies, mail-order pharmacies, and other technology-driven pharmacy solutions. MedAvail differentiates itself through its MedCenter kiosks and SpotRx platform, which offer on-site prescription dispensing and real-time pharmacist supervision. The company's success depends on its ability to capture market share in a competitive environment and adapt to evolving consumer preferences and regulatory requirements.
Key Customers
- Patients seeking convenient access to prescription medications.
- Healthcare providers looking to improve patient outcomes and streamline prescription fulfillment.
- Employers seeking to provide on-site pharmacy services to their employees.
Financials
Chart & Info
MedAvail Holdings, Inc. (MDVL) stock price: Price data unavailable
Latest News
-
Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
benzinga · Dec 21, 2023
-
Stocks That Hit 52-Week Lows On Wednesday
benzinga · Apr 26, 2023
-
Stocks That Hit 52-Week Lows On Tuesday
benzinga · Apr 25, 2023
-
Earnings Scheduled For November 10, 2022
benzinga · Nov 10, 2022
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for MDVL.
Price Targets
Wall Street price target analysis for MDVL.
MoonshotScore
What does this score mean?
The MoonshotScore rates MDVL's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Latest News
Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Stocks That Hit 52-Week Lows On Wednesday
Stocks That Hit 52-Week Lows On Tuesday
Earnings Scheduled For November 10, 2022
Leadership: Emilia Keric
CEO
Emilia Keric serves as the Chief Executive Officer of MedAvail Holdings, Inc. Her background encompasses extensive experience in healthcare management and technology-driven solutions. Prior to joining MedAvail, she held leadership positions at various healthcare organizations, where she focused on improving operational efficiency and enhancing patient care through innovative technologies. She brings a wealth of knowledge in strategic planning, business development, and team leadership to her role at MedAvail. Her academic credentials include a degree in healthcare administration and certifications in project management.
Track Record: Under Emilia Keric's leadership, MedAvail Holdings, Inc. has focused on expanding its MedCenter kiosk network and enhancing the SpotRx platform. She has overseen the implementation of strategic partnerships with healthcare providers and employers to drive growth and improve market penetration. Her focus has been on streamlining operations, reducing costs, and improving the company's financial performance. She is responsible for guiding the company through a period of transformation and growth.
What Investors Ask About MedAvail Holdings, Inc. (MDVL)
What does MedAvail Holdings, Inc. do?
MedAvail Holdings, Inc. is a technology-enabled retail pharmacy company that develops and commercializes self-service pharmacy solutions. The company operates MedCenter kiosks, which are on-site pharmacy kiosks that provide patients with convenient access to prescription medications. These kiosks feature an audio-visual connection to a live pharmacist, ensuring real-time supervision and patient counseling. MedAvail also owns and operates the SpotRx retail pharmacy platform, which offers online prescription refills and delivery services. The company's goal is to improve access to prescription medications and enhance the pharmacy experience for patients.
What do analysts say about MDVL stock?
Analyst coverage of MedAvail Holdings, Inc. (MDVL) is pending, but key valuation metrics and growth considerations can be assessed. The company's market capitalization of $0.00B reflects its small size and potential for growth. The negative P/E ratio of -0.05 and profit margin of -110.5% indicate current losses and the need for improved profitability. The company's growth potential lies in its ability to expand its MedCenter kiosk network, increase adoption of the SpotRx platform, and forge strategic partnerships with healthcare providers. Investors should monitor the company's financial performance and progress in achieving profitability.
What are the main risks for MDVL?
MedAvail Holdings, Inc. faces several risks, including competition from traditional retail pharmacies and mail-order pharmacies. The company also faces regulatory risks associated with pharmacy operations, as well as the risk of technological obsolescence. The company's negative profitability and high operating expenses pose a significant challenge to its long-term success. Dependence on strategic partnerships for growth also creates a risk, as the company's performance is tied to the success of these partnerships. Investors should carefully consider these risks before investing in MDVL.
What are the key factors to evaluate for MDVL?
MedAvail Holdings, Inc. (MDVL) currently holds an AI score of 49/100, indicating low score. Key strength: Innovative MedCenter kiosk technology.. Primary risk to monitor: Potential: Competition from traditional retail pharmacies and mail-order pharmacies.. This is not financial advice.
How frequently does MDVL data refresh on this page?
MDVL prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven MDVL's recent stock price performance?
Recent price movement in MedAvail Holdings, Inc. (MDVL) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Innovative MedCenter kiosk technology.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider MDVL overvalued or undervalued right now?
Determining whether MedAvail Holdings, Inc. (MDVL) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying MDVL?
Before investing in MedAvail Holdings, Inc. (MDVL), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on available information as of 2021-12-31.
- AI analysis is pending and may provide additional insights.